Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H42O4 |
| Molecular Weight | 430.62 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC(=O)[C@]23C)O[C@]16CC[C@@H](C)CO6
InChI
InChIKey=QOLRLLFJMZLYQJ-LOBDNJQFSA-N
InChI=1S/C27H42O4/c1-15-7-10-27(30-14-15)16(2)24-22(31-27)12-21-19-6-5-17-11-18(28)8-9-25(17,3)20(19)13-23(29)26(21,24)4/h15-22,24,28H,5-14H2,1-4H3/t15-,16+,17+,18+,19-,20+,21+,22+,24+,25+,26-,27-/m1/s1
| Molecular Formula | C27H42O4 |
| Molecular Weight | 430.62 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/22426163Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/25115457
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22426163
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/25115457
Hecogenin is the steroidal saponin aglycone (or sapogenin) present in the leaves of species from the Agave genus, including Agave sisalana, Agave cantala and Agave aurea. Hecogenin has a wide spectrum of pharmacological activities already studied, including anticancer/antiproliferative, antifungal and hipotensive activities. A recent study showed that this substance is a selective inhibitor of human UDP-glucuronosyltransferases, enzymes responsible for the detoxification of numerous chemical toxins
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3619 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25448279 |
4.2 µM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27684191
The anti-inflammatory effects of Hecogenin (50 µg/animal) was investigated on various inflammatory models. The anti-inflammatory effect of HG, was studied on % inhibition of dry weight of granuloma tissue, Δ ear weight, myeloperoxidase assay, serum pro-inflammatory cytokines, colon weight to length ratio, macroscopic lesions, adhesion score, diarrhoea score and histopathological analysis of ear and colon tissue on Cotton pellets induced granuloma in rats, Croton oil induced ear edema in mice and TNBS induced granuloma in rats.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25448279
UGT1A4 inhibition by hecogenin (0-20 µM) was evaluated in imipramine N-beta-D-glucuronidation assay.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:36:24 GMT 2025
by
admin
on
Mon Mar 31 22:36:24 GMT 2025
|
| Record UNII |
3XP44JJ79F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
3773 (Number of products:2)
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
207-392-4
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY | |||
|
3XP44JJ79F
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY | |||
|
DTXSID7045310
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY | |||
|
91453
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY | |||
|
115921
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY | |||
|
m5927
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
467-55-0
Created by
admin on Mon Mar 31 22:36:24 GMT 2025 , Edited by admin on Mon Mar 31 22:36:24 GMT 2025
|
PRIMARY |